Liminatus Pharma, Inc. Class A Common Stock LIMN · Insights

website

Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedi...

Price2.71

Market Cap3.64 M

Float995.71 K

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

Key Dates & Timelines

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro

Financial Transactions

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro